Predicted to enable GTPase activating protein binding activity and RNA binding activity. Predicted to act upstream of or within positive regulation of cell-cell adhesion; positive regulation of phagocytosis; and protein localization to cell cortex. Predicted to be located in P-body; cytosol; and nucleoplasm. Orthologous to human MEX3B (mex-3 RNA binding family member B); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3,4-dichloroaniline; 6-propyl-2-thiouracil.
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA and [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEX3B mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA and [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEX3B mRNA